Alpha Teknova (NASDAQ:TKNO) Now Covered by Analysts at Craig Hallum

Craig Hallum began coverage on shares of Alpha Teknova (NASDAQ:TKNO) in a research report released on Monday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $12.00 price target on the stock.

Alpha Teknova Trading Up 1.8 %

Shares of NASDAQ TKNO opened at $9.17 on Monday. The stock has a market cap of $488.85 million, a P/E ratio of -12.39 and a beta of 0.34. The firm has a 50 day moving average price of $8.47 and a two-hundred day moving average price of $6.50. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. Alpha Teknova has a 52-week low of $1.15 and a 52-week high of $10.37.

Institutional Investors Weigh In On Alpha Teknova

Large investors have recently modified their holdings of the company. State Street Corp lifted its stake in Alpha Teknova by 249.3% in the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after buying an additional 54,700 shares during the period. Point72 Asset Management L.P. acquired a new position in shares of Alpha Teknova during the 3rd quarter valued at $1,483,000. Roubaix Capital LLC acquired a new position in shares of Alpha Teknova during the 3rd quarter valued at $2,015,000. Geode Capital Management LLC boosted its stake in Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after acquiring an additional 36,914 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. bought a new stake in Alpha Teknova in the fourth quarter valued at $94,000. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.